Overview

Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of ursodeoxycholic acid (UDCA) and fenofibrate is more effective than UDCA alone in the treatment of primary biliary cirrhosis.
Phase:
Phase 2
Details
Lead Sponsor:
University of Miami
Collaborator:
Mayo Clinic
Treatments:
Fenofibrate
Ursodeoxycholic Acid